Peloton Therapeutics

Acquired

United States | Cancer, HIF2-a

United States · Founded 2010 · $150.0M raised

Founded
2010
Business Model
B2B
Total Funding
$150.0M
Last Round
$150.0M Series EFeb 2019
Rounds
1
Acquisition Date
May 2019

About

Peloton Therapeutics, Inc. is a clinical stage pharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions. Peloton is initially targeting HIF-2α, a transcription factor which was previously thought to be intractable using a small molecule. The company is a leader in the field of HIF-2α biology and pioneered the first HIF-2α to enter into clinical development. Peloton has opportunities to completely transform established treatment paradigms and improve patient outcomes in kidney cancer, VHL Disease, and other serious diseases.

Summary

Peloton Therapeutics is a Biotech company based in United States, founded in 2010. It has raised $150.0M in total across 1 round, most recently a $150.0M Series E round in Feb 2019. Investors include RA Capital Management.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionMay 2019

Sign up to see all 2 events

Funding: Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Peloton Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/peloton-therapeutics"><img src="https://indexed.vc/api/badge/company/peloton-therapeutics" alt="Peloton Therapeutics on Indexed.vc" width="260" height="76" /></a>